This ETF offers targeted exposure to the biotech industry, a corner of the health care sector that is capable of delivering big returns but also exhibiting significant volatility. Given that risk/return profile, accessing biotech through the exchange-traded wrapper has some obvious appeal; it allows investors to spread out exposure, thereby increasing the opportunity of holding a stock that hits it big. Given that targeted objective, this ETF is probably most useful for those seeking tactical exposure to this corner of the market; the underlying holdings are generally found in broad-based equity ETFs, so there should be little appeal to buy-and-holders.
BBH used to be structured as a HOLRDS offered by Merrill Lynch, and converted to a true ETF in 2011. It should be noted, however, that this fund still maintains some of the concentration that was characteristic of HOLDS; a few stocks receive significant allocations in the portfolio, and the top ten holdings combine to make up the majority of assets.
There are some other biotech ETFs out there that may be interesting opportunities, including IBB, XBI, FBT, and PBE. Those looking for a deep, balanced portfolio will probably prefer to avoid this Market Vectors ETF and utilize a fund such as IBB or XBI instead.
This section compares how balanced and deep this ETF is relative to its peers.
| BBH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Number of Holdings | 26 | 109 | 26 |
| % of Assets in Top 10 | 58.78% | 40.24% | 58.78% |
| % of Assets in Top 15 | 77.85% | 52.26% | 77.85% |
| % of Assets in Top 50 | 99.99% | 86.00% | 99.99% |
| BBH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Large (>12.9B) | 90.61% | 53.58% | 90.61% |
| Mid (>2.7B) | 9.39% | 25.64% | 9.39% |
| Small (>600M) | 0.00% | 14.38% | 0.00% |
| Micro (<600M) | 0.00% | 2.06% | 0.00% |
This section compares the P/E ratio of this ETF to its peers.
This section compares the dividend yield of this ETF to its peers.
| BBH | ETF Database Category Average | FactSet Segment Average | |
|---|---|---|---|
| Dividend | $ 0.61 | $ 0.20 | $ 0.61 |
| Dividend Date | 2020-12-21 | N/A | N/A |
| Annual Dividend Rate | $ 0.61 | $ 0.52 | $ 0.61 |
| Annual Dividend Yield | 0.31% | 0.55% | 0.31% |
View charts featuring ETF fund flow data.
5 Day Net Flows: 0 1 Month Net Flows: 4.05 M 3 Month Net Flows: 14.91 M 6 Month Net Flows: 19.52 M 1 Year Net Flows: -10.83 M 3 Year Net Flows: -56.99 M 5 Year Net Flows: -261.24 M 10 Year Net Flows: -224.97 MView charts that break down the influence that fund flows and price had on overall assets.
The adjacent table gives investors an individual Realtime Rating for BBH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETF Database Pro. To view information on how the ETF Database Realtime Ratings work, click here.
This section compares the cost efficiency of this ETF to its peers.
| Max ST Capital Gains Rate | 39.60% |
| Max LT Capital Gains Rate | 20.00% |
| Tax On Distributions | Qualified dividends |
| Distributes K1 | No |
This section shows how this ETF has performed relative to its peers.
| BBH |
ETF Database
Category Average |
Factset Segment
Average |
|
|---|---|---|---|
| 1 Month Return | -9.00% | -4.07% | -9.00% |
| 3 Month Return | -3.22% | -2.48% | -3.22% |
| YTD Return | 14.62% | 1.87% | 14.62% |
| 1 Year Return | 19.63% | 11.98% | 19.63% |
| 3 Year Return | 59.28% | 33.09% | 59.28% |
| 5 Year Return | 95.80% | 70.76% | 95.80% |
The following charts reflect the geographic spread of BBH's underlying holdings.
| Region | Percentage |
|---|---|
| North, Central and South America | 99.82% |
| Other | 0.18% |
| Country | Percentage |
|---|---|
| United States | 83.37% |
| Ireland | 5.28% |
| Germany | 3.71% |
| China | 3.28% |
| Netherlands | 2.66% |
| Switzerland | 1.52% |
| Other | 0.18% |
The following charts reflect the allocation of BBH's underlying holdings.
| Sector | Percentage |
|---|---|
| Health Technology | 85.58% |
| Health Services | 9.94% |
| Commercial Services | 4.3% |
| CASH | 0.18% |
| Market Cap | Percentage |
|---|---|
| Large | 90.61% |
| Mid | 9.39% |
| Micro | 0.0% |
| Small | 0.0% |
| Region | Percentage |
|---|
| Asset | Percentage |
|---|---|
| Share/Common/Ordinary | 92.83% |
| American Depositary Receipt | 6.99% |
| CASH | 0.18% |
| Sector | Percentage |
|---|---|
| Health Technology | 85.58% |
| Health Services | 9.94% |
| Commercial Services | 4.3% |
| CASH | 0.18% |
This section shows how the volatility of this ETF compares to the peer group ETF Database Category.
ETF Database's Financial Advisor Reports are designed as an easy handout for clients to explain the key information on a fund. Includes new analyst insights and classification data.
Fact sheets are issued by the ETF provider and framed by ETF Database. Information contained within the fact sheet is not guaranteed to be timely or accurate.
Here is a look at the 25 best and 25 worst ETFs from the past trading month. Traders can use this...
Here is a look at the 25 best and 25 worst ETFs from the past trading month. Traders can use this...
Whether we are discovering the latest sports news on Twitter, posting about our weekends on...
ETF Trends and ETF Database , the preeminent digital platforms for ETF news, research, tools, video, webcasts, native content channels, and more. The ETF Trends and ETF Database brands have been trusted amongst advisors, institutional investors, and individual investors for a combined 25 years. The firms are uniquely positioned to aid advisor’s education, adoption, and usage of ETFs, as well as the asset management community’s transition from traditionally analog to digital interactions with the advisor community.
Our team at ETF Database is committed to making our website the premier source of information on ETF investing with the world’s highest quality ETF tools, content, and resources.
ETF Database analysts have a combined 50 years in the ETF and Financial markets, covering every asset class and investment style. The team monitors new filings, new launches and new issuers to make sure we place each new ETF in the appropriate context so Financial Advisors can construct high quality portfolios.
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
With the 10-year U.S. Treasury yield hovering below 1% and Federal Reserve Chairman Jerome Powell...
Investors could be forgiven to think there was no reason to invest outside of the U.S. for the...
